What improvements would you like in Yahoo! Finance Message Boards? Please send us feedback.
Message Boards Settings Celgene Corp. (CELG) - Quote Info
Thalidomide And CC-5013 In The Treatment Of Prostate Cancer      7-Nov-09 08:50 pm    
Current Status Of Thalidomide And CC-5013 In The Treatment Of Metastatic Prostate Cancer.

Anticancer Agents Med Chem. 2009 Dec 1. [Epub ahead of print]

Sissung TM, Thordardottir S, Gardner ER, Figg WD.

Clinical Pharmacology Program, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, MD, 21702, USA. wdfigg@helix.nih.gov.

Thalidomide is emerging as a potentially important therapeutic option in the treatment of metastatic prostate cancer. Although the mechanism of action of this agent remains elusive in malignancies of the prostate, recent data has indicated that thalidomide may play a role in inflammation, immunomodulation, and anti-angiogenesis. Lenalidomide (CC-5013), a thalidomide analogue with improved activity and safety profile in certain disease contexts, is in the early stages of development in prostate cancer. This review will provide the current status of the history, mechanism, metabolism, and clinical use of thalidomide in metastatic prostate cancer. It will also describe the mechanism and clinical use of lenalidomide as it pertains to malignancies of the prostate.

PMID: 19719457 [PubMed - as supplied by publisher]
Rating :
 (No ratings)
Rate it:
awful/not related to \pooraveragegoodexcellent

buycelg

40/Male
Houston, Te...


View Messages

Ignore User

Report Abuse

< Previous Message |   Next Message >
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Messages in Topic

Minimum rating: What's this?
  Subject Author Rating Time of Post (ET)  
 
Thalidomide And CC-5013 In The Treatment Of Prostate Ca...
buycelg Not rated 7-Nov-09 08:50 pm  
View: Simple | Summary | Expanded
As: Threaded | Msg List
Page 1 of about 1   First | < Prev | Next > | Last

Celgene Corporation (CELG)

Chart for Celgene Corporation (CELG)
On Dec 11: 52.76 Down 0.63 (1.18%)
Symbol Lookup